Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Safety and Efficacy of Multimodal Thermal Therapy in the Treatment of Early-stage Invasive Breast Cancer
Sponsor: Fudan University
Summary
Multimodal thermal therapy (MTT), as an initiative integration of cryotherapy and radiofrequency heating, has been applied to treat various solid tumors. However, the feasibility and safety for MTT in the treatment of breast cancer is unknown. This prospective, open-label, single-arm phase II clinical study aimed to evaluate the efficacy and safety of MTT in the treatment of early-stage invasive breast cancer, and to explore the ablation-induced immune activating response.
Official title: A Prospective, Single-center, Single-arm Phase II Clinical Trial to Evaluate the Safety and Efficacy of Multimodal Thermal Therapy in the Treatment of Early-stage Invasive Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-10-08
Completion Date
2026-10-07
Last Updated
2024-10-10
Healthy Volunteers
No
Conditions
Interventions
Multimodal Tumor Thermal Therapy System (Shanghai MAaGI Medical Technology Co., Ltd.)
These patients will receive multimodal thermal therapy using Multimodal Tumor Thermal Therapy System.
Locations (1)
Breast cancer institute of Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, China